CIT-Logo-White Created with Sketch.

MENU
Device Guides
Trial Guide
Centers
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | January/February 2021

Left Atrial Appendage Closure: An Update

Reviewing the latest literature, current devices, and procedural considerations for prevention of stroke in patients with nonvalvular atrial fibrillation.

By Cameron McAlister, MD, FRACP, and Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, FSCCT

cit | News | August 25, 2021

Baylis Medical VersaCross Large-Access Solution Used in First Clinical Case in Canada

August 25, 2021—Baylis Medical announced the first clinical use of the company’s VersaCross large-access solution in Canada.

cit | News | June 7, 2021

Abbott’s Amplatzer Steerable Delivery Sheath Approved in Europe and Canada for LAA Closure

June 7, 2021—Abbott announced it has received CE Mark approval and Health Canada approval for its Amplatzer steerable delivery sheath, which is used with the company’s Amplatzer Amulet left atrial appendage (LAA) occluder.

cit | News | March 27, 2023

SCAI and HRS Publish Expert Consensus on Transcatheter Left Atrial Appendage Closure

March 27, 2023—The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) announced the publication of an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC).

Advertisement

cit | News | October 14, 2021

FEops HeartGuide Platform Cleared by FDA for LAAO Planning With Watchman Device

October 14, 2021—FEops announced that it received de novo authorization from the FDA for the company’s HeartGuide for left atrial appendage occlusion (LAAO) with the Watchman device (Boston Scientific Corporation).

cit | Article | January/February 2021

Physiology-Guided PCI: Surveying the FFR Paradigm

Plus: Updates on PFO and LAA Closure

By Yuhei Kobayashi, MD

Advertisement

Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button